Loading
Albert Hsia

Albert Hsia, PhD

Executive Director, Business Development & Licensing
Merck
Albert Hsia is Executive Director, Business Development at Merck where he leads Oncology and Immunology business development at Merck’s Boston Hub, focusing on partnership and M&A opportunities to accelerate the development of innovative medicines. Albert brings over two decades of biopharma business and corporate development experience, including eight years at Merck and, prior to Merck, at Disarm Therapeutics (now Lilly), Atlas Venture, Genewave (now Hologic), and Synta Pharmaceuticals (now Madrigal Pharmaceuticals). He holds a Ph.D. from U.C. San Francisco and a B.A. from Harvard University.
Speaking In
  • 17-Jun-2025
    Merck
    153B

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS